ArticleThe Journal of infectious diseases2020

Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3.

Martin Markowitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.